News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Mergers and Acquisitions (World)
Sanofi (SNY) Heats Up Medivation (MDVN) Bid With Letter Threatening a Hostile Takoever 5/5/2016
Sanofi (SNY) CEO Sees a Strong Strategic Fit with Medivation (MDVN) 5/5/2016
Luye Medical Welcomes Australia's Healthe Care To Its Group, Leading The Way For Group Expansion In Asia 5/5/2016
Bay Area’s Medivation (MDVN) Shores Up Defenses as Pfizer (PFE) Rumored to Join Sanofi (SNY) in Acquisition Bid 5/4/2016
Axiogenesis Secures Major Funding For Its Expansion Course 5/3/2016
Why a Medivation (MDVN) Takeover Just Got a Little Tougher for Potential Suitors Like AstraZeneca PLC (AZN), Pfizer (PFE) and Sanofi (SNY) 5/3/2016
Sinocare Coughs Up $200 Million Cash for PTS Diagnostics 5/2/2016
4SC AG (VSC.F) Sells Operations Of Its Discovery Division 4/29/2016
Medivation (MDVN) Says No! to Sanofi (SNY)'s $9.3 Billion Hostile Bid 4/29/2016
AstraZeneca PLC (AZN) Stays Mum on M&A, Says “No Comment” to Medivation (MDVN) Bid 4/29/2016
Sanofi (SNY) Makes Hostile $9.3 Billion Bid for Bay Area’s Medivation (MDVN) 4/29/2016
Rumors Surface Again About AstraZeneca PLC (AZN), Sanofi (SNY) or AbbVie (ABBV) Acquiring Medivation (MDVN) 4/27/2016
Toshiba Got the Cash for Its Medical Biz Before the Deal Closed 4/27/2016
Nokia Bets on Digital Health with $190 Million Buy 4/27/2016
Ironwood (IRWD) to Fork Over Up to $256 Million Plus Royalties to AstraZeneca PLC (AZN) for U.S. Rights to Gout Drug 4/26/2016
Novartis AG (NVS) Mulls Over Selling $14 Billion Roche (RHHBY) Stake to Potentially Free Up Cash for New Deals 4/26/2016
Singapore-Based Luye Medical Group Completes Acquisition Of Healthe Care, Australia's Third Largest Private Healthcare Group 4/25/2016
Allergan (AGN) Makes Another Deal, Bags Boston's Topokine for $85 Million+ 4/25/2016
Biogen (BIIB), Regeneron (REGN) and Valeant (VRX) Rank High as Potential Takeover Targets for Allergan (AGN) 4/22/2016
Bionik Laboratories Announces Closing Of Acquisition Of Interactive Motion Technologies Inc. 4/21/2016
Allergan (AGN)'s Potential Shopping List Expands 4/19/2016
A Week After Medivation (MDVN) Rumored to Snub Sanofi (SNY) Bid, AstraZeneca PLC (AZN) in Talks to Make Its Own $10 Billion Offer 4/19/2016
Recipharm AB Creates A Global CDMO Leader Through SEK 1.7 Billion Strategic Acquisitions In The US, Sweden And India 4/18/2016
China’s Venus Medtech Snaps Up Transcatheter Technologies 4/18/2016
If Pfizer (PFE) Wants to Buy, Here’s a Shopping List 4/15/2016
OSE Pharma And Effimune Announce The Signing Of The Merger Treaty To Create OSE Immunotherapeutics 4/15/2016
WuXi AppTec Acquires CRELUX GmbH 4/15/2016
Advent, Baxter International (BAX) Preparing Bids for Private Indian Drugmaker Gland Pharma 4/15/2016
New Jersey's Catalent (CTLT) Jumps on Rumors of Lonza Group (LZAGY.PK)'s Takeover Bid 4/14/2016
Bay Area’s Medivation (MDVN) Stock Pops 11% After Rumors It Rejected A Sanofi (SNY) Acquisition Bid 4/14/2016
EUSA Pharma Announces Acquisition Of Global Rights To Next Generation Oncology Supportive Care Product Arcoral Tab From Arcoral Pharma 4/12/2016
The Valence Group Advises Eurazeo On Its Acquisition Of Novacap From Ardian 4/12/2016
Incoming Bayer (BAY) CEO Has Big Plans to Beef Up Animal Health Unit with Deals and Acquisitions 4/12/2016
Ossur (OSSR) Coughs Up $39 Million for Touch Bionics 4/11/2016
Recipharm AB Completes Acquisition Of A Majority Stake In Indian CMO Nitin Lifesciences 4/11/2016
Shire (SHPG) Not Spooked by Pfallergan Breakup, Remains Committed to Baxalta (BXLT) 4/7/2016
Nixed Pfallergan Deal Has Investors Wondering if Allergan (AGN) Might Target Biogen (BIIB) 4/7/2016
Pfizer (PFE) Formally Calls Off $160 Billion Allergan (AGN) Deal 4/7/2016
U.S. Treasury Drops Bomb on Tax Inversion Deals, Threatens Pfizer (PFE)-Allergan (AGN) Merger 4/6/2016
Companies Allergan (AGN) Could Buy if Deal with Pfizer (PFE) Falls Through 4/6/2016
Twist Bioscience Acquires Genome Compiler To Add Gene Design Capabilities 4/6/2016
Pfizer (PFE) Inside Source Says Company Considering Abandoning Allergan (AGN) Deal 4/6/2016
MediGene AG (MDGEF.PK) Sells Partial Stake In Immunocore 4/4/2016
Repligen (RGEN) Buys Germany's Atoll GmbH in Cash and Stock Deal Worth $22.5 Million 4/4/2016
Luye Pharma Group Ltd. Bids To Acquire France's Ethypharm In Deal Worth Up To $900 Million 4/1/2016
Mallinckrodt (MNK) Rumored to be Eyeing Sale of Nuclear Imaging Unit, Biz Could Fetch $800 Million to $1 Billion 3/31/2016
DiaSorin S.p.A. Shells Out $300 Million for Quest Diagnostics (DGX)'s Focus Diagnostics 3/30/2016
QIAGEN N.V. (QGEN) Makes $100 Million Bid to Buy Exiqon A/S 3/30/2016
Wuhan Humanwell Acquires U.S. Generic Drugmaker for $550 Million 3/30/2016
As Flailing Valeant (VRX) Pushes Back Earnings Deadlines, Bausch & Lomb Sale Potentially on the Table 3/30/2016
Sun Pharma (SUNPHARMA.NS) Snaps Up 14 Japanese Brands From Novartis AG (NVS) in $293 Million Deal 3/30/2016
Alten Calsoft Labs Acquires A Niche CRO Services Company PVR Technologies To Strengthen Its Healthcare And Life Sciences Business 3/29/2016
Onxeo Announces Closing Of DNA Therapeutics Acquisition 3/28/2016
Yantai Dongcheng Acquires China Ops Of Global Medical Solutions For $70 Million 3/28/2016
NDA Group And PharmApprove Announce Merger 3/22/2016
Bone Medical Ltd Announces Acquisition Of US-based Botanix Pharmaceuticals 3/22/2016
Scandal-Plagued Toshiba Inks Deal to Sell Medical Biz to Canon (CAJ) for $5.9 Billion 3/18/2016
AstraZeneca PLC (AZN) Snaps Up All Rights to Orexo (ORXOF)'s OX-CLI Project 3/17/2016
Top Five Allergan (AGN) Execs Could Get $300 Million Golden Parachutes Plus Another $86 Million Tax Break If They Lose Jobs 3/16/2016
Grunenthal To Acquire Almirall de Mexico, S.A. de C.V. 3/16/2016
Gyros AB And Protein Technologies Merge To Form Gyros Protein Technologies AB 3/16/2016
UK's Vectura (VEC.L) Buys Skyepharma (SKYEF) for $620 Million to Create Powerful Respiratory Company 3/16/2016
HUYA Bioscience Acquires Exclusive Rights To Immuno-Oncology Products From Fudan University 3/15/2016
Analyst Mulls Over The Possibility of Shire (SHPG) Acquiring Biogen (BIIB) 3/10/2016
Teva (TEVA) Receives Allergan (AGN) Approval For The Allergan (AGN) Generics Acquisition 3/10/2016
Toshiba Gives Canon (CAJ) Exclusive Negotiating Rights for Its $6.2 Billion Medical Biz 3/9/2016
Siemens (SI), Thermo Fisher Scientific (TMO) are Also Reportedly Seeking M&As 3/9/2016
Lupin (LUPN.BO) Completes Its Acquisition Of GAVIS 3/9/2016
Despite Losing 60% of Stock Value, Perrigo (PRGO) Execs Awarded Big Bonuses for Fending Off Mylan (MYL) 3/9/2016
Spark Therapeutics (ONCE) Snaps Up Genable Tech in $15 Million Cash-Stock Deal 3/7/2016
Merus Completes Acquisition Of Surgestone, Provames, Tredemine And Speciafoldine Rights From Sanofi (SNY) 3/7/2016
Bionik Laboratories Enters Into Merger Agreement To Acquire Interactive Motion Technologies, Inc. (IMT) 3/7/2016
More Clarity on Who Could Buy Troubled Toshiba's Medical Unit 3/7/2016
Deal-Hungry Sanofi (SNY) Wants a Piece of the Rare Disease Cake But Price Tag May be Higher Than Its $20 Billion Budget 3/4/2016
FUJIFILM, Canon (CAJ) are Frontrunners for Toshiba’s Medical Device Biz 3/4/2016
Siemens Healthcare (SI) Interested in Further Takeovers 3/3/2016
Teva (TEVA) Completes Acquisition Of Rimsa 3/3/2016
Evonik Industries Acquires Norwegian Manufacturer Of Food Ingredients 3/3/2016
Sources Say Sanofi (SNY)’s European Generics Business Sale May Be Delayed or Abandoned 3/2/2016
Galapagos (GLPG.BR) Receives Transparency Notification From Johnson & Johnson (JNJ) 3/2/2016
PE Firm Slaps $1.1 Billion Price Tag on Atos Medical 3/2/2016
AstraZeneca PLC (AZN) Continues to Unload the Excess Fat with $70 Million Moventig Deal 3/1/2016
Synexus Expands Global Capability And Enters U.S. Market With Acquisition Of Research Across America 3/1/2016
Struggling Toshiba to Sell Entire Medical Unit 2/29/2016
AstraZeneca PLC (AZN) Unloads Two Heart Drugs to China Medical for $500 Million 2/29/2016
Mindray Medical Announces Shareholders' Approval Of Merger Agreement 2/26/2016
ICIG Snaps Up Novartis AG (NVS) Site that Was Set to Shut Down, 270 Pharma Jobs Saved 2/25/2016
MedGenome Bags Lifecode Health’s Assets Including It’s Lab in Foster City 2/25/2016
OSE Pharma And Effimune Announce Proposed Merger To Create Significant Immunotherapy Player 2/24/2016
Merus Buys Four Products from Sanofi (SNY) for €22.5 Million 2/23/2016
GlaxoSmithKline (GSK)'s Global HIV Business ViiV Healthcare Completes Transactions To Acquire Bristol-Myers Squibb (BMY)'s R&D HIV Assets 2/22/2016
Primex Pharma: New Acquisition Brings An Innovative Oral Solution For Pediatric Anesthesiology To The Market 2/22/2016
PE Firms in Talks to Buy Stake in SRL Diagnostics 2/19/2016
Novartis AG (NVS) Snaps Up Transcend Medical to Beef Up Eye Surgery Pipeline 2/18/2016
DiagnoCure (CUR) Announces Closing Of The PCA3 Asset Sale Transaction And Special Distribution To Its Shareholders, By Way Of Due Bills, Of Proceeds From The Sale Of Its PCA3 Assets 2/18/2016
Air Liquide Announces The Acquisition Of A Service Leader Specialized In Temperature-Controlled Logistics For The Pharmaceutical Industry 2/16/2016
Why Sanofi Genzyme (SNY) is Still Defying the Odds Five Years After Being Acquired 2/16/2016
Investors And Scientists Question Whether Brent Saunders Will "Get Religion" And Support Pfizer (PFE)'s Internal R&D 2/11/2016
Mylan (MYL) Snaps Up Swedish Drugmaker MEDA in $7.2 Billion Deal 2/11/2016
Hikma (HIK.L) Halves Cash Offer for Boehringer Ingelheim's Roxane, Will Pay $575 Million Less 2/10/2016
Astellas (ALPMY) Announces Results Of Tender Offer To Acquire All Outstanding Shares Of Ocata And Changes To Subsidiaries 2/10/2016
Halma Coughs Up $140 Million for CenTrak 2/8/2016
Henry Schein (HSIC) To Acquire A Majority Interest In Brazil's Dental Cremer 2/5/2016
Merus Completes Acquisition Of Elantan, Isoket And Deponit Rights From UCB And Announces Date Of Q1 2016 Earnings Release 2/5/2016
Bay Area's Pacific Biosciences (PACB) Stock Pops on Roche (RHHBY) Acquisition Bid Rumors 2/4/2016
Sinovac Biotech Ltd. (SVA) Announces Receipt of Competing Non-Binding "Going Private" Proposal 2/4/2016
Pharmaron LLC Acquires Quotient BioResearch 2/4/2016
Deal Spree for AstraZeneca PLC (AZN) Pretty Much Over as CEO Says "We Have What We Need to Have" 2/4/2016
TRANSGENE (ENX:TNG) And ABL Announce The Acquisition By ABL Europe Of Transgene’s Production Asset 2/3/2016
TE Connectivity Bags Creganna for $895 Million Cash 2/2/2016
Merus Snags Three Cardiovascular Products from UCB Group (UCBJF.PK) in EUR 92 Million Deal 2/2/2016
The Institute of Cancer Research, London Sells A Portion Of Its Royalty Entitlement Relating To Sales Of Johnson & Johnson (JNJ)’s Zytiga To Dri Capital Managed Fund 2/2/2016
Medtronic (MDT) Buys Bellco in Firm's First Acquisition of 2016 2/2/2016
Sinovac Biotech Ltd. (SVA) Announces Receipt Of A Preliminary Non-Binding Proposal To Acquire The Company And Formation Of Independent Special Committee 2/1/2016
Mallinckrodt (MNK) Completes Acquisition Of Three Commercial-Stage, Global Specialty Hemostasis Brands From The Medicines Company (MDCO) 2/1/2016
Trillium Therapeutics Inc. Acquires Fluorinov Pharma 1/28/2016
PE Firms and Rival Corporations in Bidding War for Toshiba Medical Systems 1/27/2016
PerkinElmer (PKI) Acquires Vanadis Diagnostics 1/26/2016
Perrigo (PRGO) Completes The Acquisition Of Generic Retin-A Portfolio, Further Enhancing Rx "Extended Topicals" Strategy 1/25/2016
Astellas (ALPMY) Extends Tender Offer To Acquire All Outstanding Shares Of Ocata 1/22/2016
Medqualis, A Canadian Clinical Research Organization Announces The Sale Of Its Biomedical Research Activities To The Division Keyrus Biopharma, Member Of The Keyrus Group 1/21/2016
Kuros Biosurgery Holding Ltd. Closes Merger With Cytos Biotechnology Ltd. Which Is Renamed Kuros Biosciences 1/20/2016
Pfizer (PFE) and Allergan (AGN) Execs Emphasize Joint Company’s Pipeline, Hint Job Cuts Will Be Minimal 1/14/2016
Cardiome Pharma Corp. (COM.TO) Announces Share Purchase Agreement With Lincoln Park Capital Fund, LLC 1/12/2016
Roche (RHHBY) Takes a $535 Million Chance on Cambridge's Tensha Therapeutics 1/12/2016
After a 6-Month Courtship, Baxalta (BXLT) Finally Says Yes to $32 Billion Shire (SHPG) Marriage Proposal 1/12/2016
Covalon Technologies Ltd. Chairman Acquires Additional Shares And Warrants 1/11/2016
Shire (SHPG) Rumored to Announce $32.5 Billion Merger as Early as Monday, Deal Hinges on Baxalta (BXLT) Tax Status 1/8/2016
AmpliPhi Biosciences Corporation (APHB) Acquires Key Bacteriophage Assets From UK-based Novolytics 1/8/2016
Allergan (AGN) Pays $90 Million+ for Anterios to Expand Neurotoxin Pipeline 1/7/2016
Golden Meditech Enters Into Agreements With Nanjing Xinjiekou To Sell China Cord Blood Corporation 1/7/2016
Takeda (TKPYY) Buys a U.S. Biologics Manufacturing Facility from Baxalta (BXLT) 1/6/2016
MACROGEN To Execute Merger Of Its Three U.S. Affiliates Into Macrogen Corp. 1/6/2016
Shire (SHPG)'s Long Pursuit of Baxalta (BXLT) May End This Week with $32 Billion Deal 1/5/2016
Almirall Exercises Call Option To Acquire 100% Of Thermigen LLC 1/4/2016
Toshiba in Talks to Sell Toshiba Medical Systems 12/29/2015
Baxalta (BXLT) Playing Hard to Get as Shire (SHPG) Sweetens Deal 12/28/2015
Nuvo Research (NRI.TO) Reacquires Pliaglis North American Development And Marketing Rights 12/22/2015
BTG plc (BTG.L) Chief Scours for Next Deals as Lung Device Bet Pays Off 12/18/2015
Halma Snaps Up Visiometrics in £91.2 Million Deal 12/18/2015
GlaxoSmithKline (GSK) Does Late Holiday Shopping, Buys Two HIV Asset Programs from Bristol-Myers Squibb (BMY) For Up to $2 Billion 12/18/2015
The Medicines Company (MDCO) to Sell Its Hemostatis Portfolio to Mallinckrodt (MNK) in Deal Worth $410 Million 12/18/2015
Midatech Bags Galena Biopharma  (GALE)'s Zuplenz in ~$29.75 Million Deal 12/18/2015
AstraZeneca PLC (AZN) Takes 55% Stake in Acerta Pharma for $4 Billion with Option to Buy Rest for Another $3 Billion 12/18/2015
Perrigo (PRGO) Acquires Generic Retin-A Portfolio, Furthering Rx "Extended Topicals" Strategy 12/17/2015
AstraZeneca PLC (AZN) Beefs Up Respiratory Biz with $575 Million Takeda (TKPYY) Deal 12/16/2015
Amgen (AMGN) Reclaims Drug Rights from GlaxoSmithKline (GSK) in Plan to Grow Internationally 12/16/2015
Toshiba Medical Systems Denies Rumored Sale of Medical Business 12/16/2015
Shire (SHPG) Still Wooing Baxalta (BXLT), But Biogen (BIIB) Might Crash the Party 12/15/2015
Pharma Giant AstraZeneca PLC (AZN) in Advanced Talks to Buy Acerta Pharma for $5 Billion+ 12/15/2015
Athenex Announces Recent Business Developments Including The Acquisition Of Comprehensive Drug Enterprises 12/14/2015
Analysts Tune Their Crystal Balls to 2016 M&A Prospects, Including Johnson & Johnson (JNJ), Amgen (AMGN), Biogen (BIIB), Sanofi (SNY) and Others 12/14/2015
After Dropping Depomed (DEPO), Horizon Pharma (HZNP) Forks Over $510 Million Cash for Crealta Holdings 12/11/2015
Teva (TEVA) Announces Closing Of Public Offerings Of American Depositary Shares And Mandatory Convertible Preferred Shares In Connection With Pending Acquisition Of Actavis (ACT) Generics 12/8/2015
Luye Pharma Group Ltd. Buys Australian Hospital China For $688 Million 12/8/2015
Medtronic (MDT) CEO Ponders Over Sale of Some Covidien (COV) Assets 12/7/2015
ICON Acquires PMG Research 12/7/2015
VC-Backed Kuros Biosurgery Merges with Cytos Biotech 12/3/2015
Pfizer (PFE) CEO Contemplates $42 Billion Tax Hit As Pfallergan Deal Inspires Corporate Tax Discussions 12/2/2015
GHO Capital Acquires Quotient Clinical 12/2/2015
Novartis AG (NVS) Considers Selling Contact Lens Care Unit Alcon (ACL) 12/1/2015
MEDA Divests Manufacturing Unit EuroMed for EUR82 Million Cash 12/1/2015
Almirall Gains a Dermatory-Focused R&D Structure with $386.3 Million Buy 11/30/2015
Investment Bank Works with Sanofi (SNY) to Unload $12.7 Billion Animal Health Biz 11/30/2015
Pfizer (PFE), Allergan (AGN) Merger Could Result in More Than 10,000 Layoffs, Analyst Says 11/30/2015
Eisai Inc. (ESALF.PK) Divests Clinical Diagnostics Supply Biz for $183 Million 11/30/2015
Pfallergan Makes Pfizer (PFE) Teva (TEVA)'s Largest Shareholder 11/25/2015
As Pfizer (PFE)-Allergan (AGN) Marry, Already Planning the Divorce 11/25/2015
Why the Union of Pfizer (PFE)-Allergan (AGN) May Not Lead to New Drugs 11/25/2015
Shire (SHPG) Rumored To Be Sweetening the Pot for Another Baxalta (BXLT) Bid 11/25/2015
WuXi PharmaTech (WX) Announces Shareholders' Approval Of Merger Agreement 11/25/2015
Pfizer (PFE) Marries Allergan (AGN) in $160 Billion Deal With Pfizer’s Read to Stay as CEO and Chairman 11/25/2015
AstraZeneca PLC (AZN) Sells Crohn's Drug Rights to Perrigo (PRGO) for $380 Million 11/23/2015
Pfizer (PFE)-Allergan (AGN) Talks About a $3-4.5 Billion Break-Up Fee, Making Allergan the Buyer Instead 11/23/2015
Mylan (MYL) Completes Acquisition Of Certain Businesses From Famy Care To Create A Leading Women's Healthcare Franchise 11/20/2015
Pfizer (PFE) Rumored to Pay Up to $150 Billion for Allergan (AGN) in Record-Breaking Deal 11/20/2015
ams Acquires CMOSIS for $235.8 Million 11/20/2015
Horizon Biopharm Pulls Out of $2 Billion Hostile Takeover Bid for Depomed (DEPO) After Court Ruling 11/20/2015
Pfizer (PFE), Servier Snap Up Right to Cellectis (ALCLS)' Blood Cancer Therapy in $338 Million+ Deal 11/19/2015
Third Point's Dan Loeb Talks Up An Amgen (AMGN)-Allergan (AGN) Merger 11/19/2015
Sources Reveal Glenmark Pharma, Sun Pharma (SUNPHARMA.NS), Cipla (CIPLA) are Exploring Bids Worth $500-800 Million for Teva (TEVA)'s Generics Products Portfolio 11/19/2015
Charles River Bags Oncotest GmbH in $38 Million Deal 11/19/2015
Medtronic (MDT) Smacks Down $110 Million Cash for Aircraft Medical 11/18/2015
Pfizer (PFE)-Allergan (AGN) Deal is Contingent Upon Saunders Becoming CEO 11/17/2015
Pfizer (PFE)-Allergan (AGN) Combo: Facility Numbers, the Biggest Headcount Since Wyeth (WYE) and R&D Philosophy 11/16/2015
Mylan (MYL) Spurned Again as Perrigo (PRGO) Rejects $26 Billion Takeover Bid 11/13/2015
LEO Pharma Puts Up €675 Million for Astellas (ALPMY)'s Global Dermatology Biz 11/11/2015
Astellas (ALPMY) Snaps Up Stem Cell Pioneer Ocata in $379 Million Deal 11/10/2015
In Largest M&A Year, a Pfizer (PFE)-Allergan (AGN) Deal Could Lead to a Pfizer Breakup 11/10/2015
AstraZeneca PLC (AZN) Coughs Up $2.7 Billion for Bay Area's ZS Pharma (ZSPH) and its Hyperkalemia Treatment 11/9/2015
Sanofi (SNY) CEO Aims to Slim Down Company and Put Some Assets Under Review 11/9/2015
Pfizer (PFE) Semi-Officially Abandons GlaxoSmithKline (GSK) Bid and Turns Gaze to Allergan (AGN) 11/9/2015
While in Limbo with Pfizer (PFE), Allergan (AGN) Picks Up a Medical Device Firm 11/5/2015
Mindray Medical Enters Into Definitive Merger Agreement For Going Private Transaction 11/4/2015
Mylan (MYL) Receives U.S. FTC Clearance For Proposed Acquisition Of Perrigo (PRGO) And Confirms Governance Changes For The Combined Mylan-Perrigo Company 11/4/2015
Elbit Imaging Ltd. (EMITF) Announces Closing Of Transaction For Sell Of Elbit Medical Technologies Shares And Exercise Of Elbit Medical Exercise-Free Options 11/4/2015
Shire (SHPG)'s New Buy Dyax (DYAX) is Another Biotech with Ties to Genzyme 11/4/2015
Brent Saunders, in Shadow of Pfizer (PFE) Acquisition, Took Allergan (AGN) from $25 Billion to $120 Billion 11/4/2015
Still Yearning for Baxalta (BXLT), Shire (SHPG) Snaps Up Dyax (DYAX) in $5.9 Billion Deal 11/3/2015
Lumenis (LUME) Acquires Israeli-Based Pollogen Strengthening and Expanding Its Aesthetic Division 11/2/2015



//-->